Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04324021 |
|---|---|
| Brief Title: | Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. |
| First Submitted : | March 25, 2020 |
| First Submitted that Met QC Criteria : | March 25, 2020 |
| First Posted : | March 27, 2020 |
| Results First Submitted : | November 29, 2021 |
| Results First Posted with QC Comments : | December 2, 2021 |
| Results First Submitted that Met QC Criteria : | March 3, 2022 |
| Results First Posted : | March 10, 2022 |
| Last Update Submitted that Met QC Criteria : | March 3, 2022 |
| Last Update Posted : | March 10, 2022 |